Related Experiment Video
Updated: Mar 22, 2026

06:37
Ubiquitous and Tissue-specific RNA Targeting in Drosophila Melanogaster using CRISPR/CasRx
Published on: February 5, 2021
3.6K
Embedded CRISPRi Enhances Gene-Silencing Efficiency in Drosophila
Pengchong Fu1,2, Xuedi Zhang1, Ying Zhou2
1School of Basic Medical Sciences, Suzhou Medical College, Soochow University, Suzhou, Jiangsu Province, China.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|March 20, 2026
Summary
Embedded CRISPR interference (emCRISPRi) enhances gene silencing in Drosophila by integrating repression domains into dCas9. This advanced tool improves efficiency for functional genomics and disease modeling.
Area of Science:
- Molecular Biology
- Genetics
- Gene Regulation
Background:
- CRISPR interference (CRISPRi) using dCas9 is a powerful gene-silencing tool.
- Current CRISPRi in Drosophila shows limitations in efficiency and repression amplitude.
- Need for improved gene-silencing technologies in Drosophila research.
Purpose of the Study:
- To develop an advanced gene-silencing platform, embedded CRISPR interference (emCRISPRi), for Drosophila.
- To enhance the efficiency and repression amplitude of CRISPRi in Drosophila.
- To validate emCRISPRi for functional genomics, enhancer studies, and disease modeling.
Main Methods:
- Engineered dCas9 by integrating Mxi and TRD repression domains into a flexible region, creating emCRISPRi.
- Tested emCRISPRi for silencing coding genes and cis-regulatory elements near transcription start sites (TSS).
- Compared emCRISPRi efficiency with RNA interference (RNAi) and assessed phenotypic rescue.
Main Results:
- emCRISPRi significantly enhanced gene-silencing efficiency and repression amplitude in Drosophila.
- Achieved robust repression of coding genes and cis-regulatory elements, especially at TSS-proximal regions.
- emCRISPRi outperformed RNAi at tested loci and enabled strong phenotypic rescue.
Conclusions:
- emCRISPRi represents a transformative advancement in Drosophila gene silencing.
- The platform is effective for functional genomics, enhancer analysis, and modeling diseases like ALS.
- emCRISPRi holds potential for cross-species applications and therapeutic development.

